Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Limited has informed BSE that its trading window for designated persons will remain closed from 1st January 2026 until 48 hours after the conclusion of the Board Meeting that will consider the Un-Audited Financial Results for the quarter ended 31st December 2025. This is a standard compliance measure under SEBI's Insider Trading Regulations to prevent insiders from trading during the quiet period before financial results are announced. The exact date of the Board Meeting has not yet been disclosed and will be communicated separately to the stock exchange.
This is a routine regulatory filing and has no direct impact on shareholders or stock price. Investors should note that Q3 FY26 results are expected to be announced in the coming weeks.